EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (iv) All cocaine (HCI and ‘crack’) outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n) Frequency unknown
Belgium53.911.123.911.138040
Bulgaria25.050.025.080
Czech Republic60.020.010.010.0100
Denmark27.350.722.015032
Germany
Estonia
Ireland132.218.043.06.850013
Greece37.922.420.519.31610
Spain123.521.932.522.2167045427
France19.815.224.240.81695571
Italy218.128.927.625.489001371
Cyprus32.48.124.335.1741
Latvia3505043
Lithuania
Luxembourg1
Hungary72.412.112.13.4581
Malta16.117.421.045.52244
Netherlands30.711.029.129.116711058
Austria37.019.919.923.314613
Poland427.318.245.59.111
Portugal537.77.920.533.83907
Romania100.012
Slovenia25.031.331.312.5162
Slovakia33.333.333.360
Finland01
Sweden146.713.333.36.7154
United Kingdom6
Croatia85.06.06.03.010016
Turkey
Norway505020
Total23.122.530.124.3312268567
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013